Q1 2023 Holdings
Filed 2023-05-15 | 14 holdings | $153.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Replimune Group(REPL) | Common Stock | 76029N106 | $53.9M | 3,050,187 | 35.1% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $25.0M | 15,072,340 | 16.3% |
| Morphic Holding | Common Stock | 61775R105 | $22.5M | 597,723 | 14.7% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $15.7M | 2,029,580 | 10.2% |
| Ikena Oncology | Common Stock | 45175G108 | $7.8M | 2,249,123 | 5.1% |
| Theseus Pharmaceuticals | Common Stock | 88369M101 | $6.3M | 711,479 | 4.1% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $5.6M | 3,818,283 | 3.6% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $5.0M | 1,971,241 | 3.3% |
| Spruce Biosciences | Common Stock | 85209E109 | $4.8M | 2,161,022 | 3.1% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $2.8M | 843,750 | 1.8% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $2.7M | 1,788,160 | 1.7% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $670.9K | 251,270 | 0.4% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $509.7K | 275,513 | 0.3% |
| Senti Biosciences, Inc. | Common Stock | 81726A100 | $231.0K | 195,792 | 0.2% |